* LeMaitre Vascular Inc LMAT.OQ LMAT.O is expected to show a
rise in quarterly revenue when it reports results on July 29.
* The Burlington, Massachusetts-based company is expected to
report a 56.7% increase in revenue to $38.951 million from
$24.85 million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for LeMaitre Vascular Inc
is for earnings of 34 cents per share. For the same quarter last
year, the company reported earnings of 21 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for LeMaitre
Vascular Inc is $59, about 8.2% above its last closing price
of $54.15.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 0.27 0.27 0.28 Beat 3.1
Dec. 31 2020 0.30 0.29 0.34 Beat 15.9
Sep. 30 2020 0.20 0.19 0.37 Beat 90.7
Jun. 30 2020 0.00 0.01 0.21 Beat 3,048.
4
Mar. 0.16 0.15 0.16 Beat 4.4
31 2020
Dec. 31 2019 0.23 0.23 0.23 Met 1.3
Sep. 30 2019 0.21 0.21 0.25 Beat 19.9
Jun. 30 2019 0.21 0.21 0.23 Beat 10.3
This summary was machine generated July 28 at 13:50 GMT. All
figures in US dollars unless otherwise stated